Cell and Gene Therapy World Congress 2024 Europe
"Driving Innovation, Addressing Significant Unmet Medical Needs, and Ultimately Improving Patient Outcomes"
3rd - 4th October 2024, Hilton London Kensington, LONDON, UK
KEY INDUSTRY EXPERT SPEAKERS
- Eric Halioua, President & Chief Executive Officer, PDC*line Pharma
- Adam Glen, Co-founder, Unicorn Bio
- Alex Blyth, Founder & CEO, Lift Biosciences
- Alexander Natz, Secretary General, EUCOPE
- Dr Lilian Hook, Director Cell, Apheresis & Gene Therapies, NHS Blood and Transplant
- Dr Theres Oakes, Head of Product Characterisation, Achilles Therapeutics
- Alberto Malerba, Lecturer in Gene Therapy, Royal Holloway University of London
- Dr. Ron Jortner, Founder/CEO, Aspire Biosciences
- Dr Nagy Habib, Professor of Surgery, Imperial College London
- Mohamed Oubihi, Founder and CEO, YAKUMED LIMITED
- Prof Harris Makatsoris, Professor of Manufacturing Systems, Department of Engineering, King’s College
- Eugean Jiwanmall, Senior Research Analyst, Independence Blue Cross
- Ana Koptina, Head of Regulatory Affairs, Mendus
- Prof Darius Widera, Prof of Stem Cell Biology & Regenerative Medicine, ERASMUS
- Dilip Patel, VP, Head of Global Market Access, Autolus
- Prof David James, Professor of Bioprocess Engineering, University of Sheffield
- Zhimei Du MD, VP of Process Sciences, Atara Biotherapeutics
- Anthony Newcomb, Chief Operating Officer, VectorY
- Cecilia Gotherstrom, Research Group leader, Associate Professor in Stem Cell Science, Karolinska Institute
- Stephen Judd, Process SME – Biologics / Cell & Gene Therapy, DPS Group
- Dr. Anand Srivastava, Chairman and Co-founder, Global Institute of Stem Cell Therapy and Research
- Amir Hefni, Global Head, Cell & Gene Therapy, Novartis
- Alejandro Fernandez-Martell, former Principal Bioprocess Engineer, Achilles Therapeutics
- Stuart M Curbishley, Chief Manufacturing and Chief Development Officer, adthera bio
- Elsa Abranches, Sr Director,Head of Cell Therapy Bioprocess Development and Manufacturing, Astrazeneca*
- Ben Doak, Head of Innovative Treatments, NHS England.
- Mark Fowler, Global Head of Procurement, Autolus
- Francois Hallac, Research Associate, King's College London
- Julia Djonova, Head, Advanced Therapy Medicinal Products, Swissmedic
- Thomas Muller, Head Of Directorate General, Federal Ministry of Health Germany
- Manal Morsy, EVP, Head of Global Regulatory Affairs, Athersys, Inc
- Yue (Dina) Du, Senior Scientist, Gene Therapy R&D, AstraZeneca
- Reagan Jarvis, Chief Executive Officer and Co-founder, Anocca
- Matthias Bozza, Director, Vector BioPharma
- Chris Williams, SVP Corporate Development, Autolus Ltd.
- Dr Lilian Hook, Director Cell, Apheresis & Gene Therapies, NHS Blood and Transplant
- Dr. Thomas Schochat, Clinical Assessor, Division Advanced Therapy Products, Swissmedic
- Daniel Gibson, Director of Cell and Gene, Anthony Nolan
- Vera Citro, P4FIT Early Stage Researcher, Keele University

Eric Halioua
President & Chief Executive Officer

JEFF LITER
CEO

ALEX BLYTH
Founder & CEO

ALEXANDER NATZ
Secretary General

DR LILIAN HOOK
Director Cell, Apheresis & Gene Therapies

DR. RON JORTNER
Founder/CEO

PROF HARRIS MAKATSORIS
Professor of Manufacturing Systems, Department of Engineering
King’s College London

PROF HARRIS MAKATSORIS
Professor of Manufacturing Systems, Department of Engineering

EUGEAN JIWANMALL
Senior Research Analyst

MARCO TRAUB
CEO

ADAM GLEN
Co-founder

ALBERTO MALERBA
Lecturer in Gene Therapy

Amir Hefni
Global Head for Cell & Gene Therapy

DR NAGY HABIB
Professor of Surgery

Dilip Patel
VP, Head of Global Market Access

MANAL MORSY
Executive Vice President, Head of Global Regulatory Affairs

THOMAS MUELLER
Head of Directorate General “Drugs, Medical Devices, Biotechnology”
Federal Ministry of Health, Germany

THOMAS MUELLER
Head of Directorate General “Drugs, Medical Devices, Biotechnology”

REAGAN JARVIS
CEO and Co-founder

BEN DOAK
Head of Innovative Treatments

CECILIA GÖTHERSTRÖM
Research Group leader, Associate Professor in Stem Cell Science
Karolinska Institutet

CECILIA GÖTHERSTRÖM
Research Group leader, Associate Professor in Stem Cell Science

Daniel Gibson
Director of Cell and Gene

STUART M CURBISHLEY
Chief Manufacturing and Chief Development Officer

JULIA DJONOVA
Head, Advanced Therapy Medicinal Products

Dr Chris Williams
SVP Corporate Development

Dr. Thomas Schochat
Clinical Assessor, Division Advanced Therapy Products

MATTHIAS BOZZA
Director